China
Zhejiang
Acute myeloid leukemia, MAP4K1, Homoharringtonine resistance, Prognosis, DNA damage, MAPK
malate dehydrogenase 1; anti-oncogene; acute myeloid leukemia
PARP-1, Acute myeloid leukemia, PARP inhibitor, SAHAbendamustine hybrid